跳至主要内容
临床试验/NCT01318967
NCT01318967已完成不适用

MRI for the Non-invasive Determination of Renal Blood Flow and Renal Oxygenation

Wake Forest University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Measurement of Renal Blood Flow of the Kidney by the PAH Method

研究概览

简要总结

Comparison of renal blood flow measurements by PAH clearance and MRI

详细描述

The traditional measurement of renal blood flow in ml/min involves the collection of multiple blood and urine samples after an infusion of a drug called para-aminohippurate (PAH) is given. In this study, the investigators determine the ability of MRI to estimate renal blood flow. The primary hypothesis is that renal blood flow as measured by PAH clearance is similar to renal blood flow as estimated by MRI. The measurements by PAH clearance and MRI are both performed on the same day.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • In this study, the investigators will enroll 16 men and women aged ≥ 18 years with Stage II - V chronic kidney disease (CKD). In addition, the investigators will enroll 4 subjects with a glomerular filtration rate (GFR) of greater than 60 ml/min who do not have any evidence of CKD.

排除标准

  • This study excludes those not suitable for MRI or for the interventional pharmacologic procedures.

研究组 & 干预措施

PAH

Placebo Comparator

PAH measure of renal blood flow is first performed on subjects prior to administration of furosemide

干预措施: Placebo (Other)

MRI after furosemide

Active Comparator

After the PAH measurement is complete, subjects receive 20 mg furosemide and undergo BOLD MRI to estimate renal blood flow

干预措施: Furosemide (Drug)

结局指标

主要结局

Measurement of Renal Blood Flow of the Kidney by the PAH Method

时间窗: Renal blood flow is estimated over 1 hour by PAH

Renal blood flow is estimated by the PAH method.

次要结局

  • Measurement of Regional Blood Oxygenation by MRI(One measure after furosemide (day 1))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验